Paragraph 2

(1)

The licensing authority must—

(a)

appoint a panel of at least two persons (“the reviewers”) to conduct the review; and

(b)

provide facilities for the applicant to have the opportunity to appear before the reviewers.

(2)

A person must not be appointed under sub-paragraph (1) if within the period of one year immediately preceding that time the person has been a member of—

(a)

the Commission;

(b)

an expert committee appointed by the licensing authority;

(c)

an expert advisory group;

(d)

the British Pharmacopoeia Commission or any of its sub-committees;

(e)

the Advisory Board on the Registration of Homoeopathic Products formerly established under section 4 of the Medicines Act 1968; or

(f)

the Herbal Medicines Advisory Committee formerly established under section 4 of the Medicines Act 1968.

(3)

A person appointed under sub-paragraph (1) must not be an officer or servant of a Minister of the Crown, the Scottish Ministers, the Welsh Ministers or a Northern Ireland Minister.